China PTCA Balloon Catheter Market Investment Report, 2009-2010
  • Nov/2010
  • Hard Copy
  • USD $1,500
  • Pages:55
  • Single User License
    (PDF Unprintable)       
  • USD $1,600
  • Code: ZYM016
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,400
  • Hard Copy + Single User License
  • USD $1,700
      
Recent years have witnessed a sharp increase in the PCI case load and the application of coronary stent in China. During 2000-2009, the CAGR of PCI case load was above 39.6% on average; and the actual consumption of coronary stent system increased by 38.4% yearly from 2002 to 2009. PTCA balloon catheter not only serves as transport system of stent, but also as device placing front pre-expansion or rear expansion of stent. Along with the evolution of PCI and coronary stent industry, China will see a huge demand in the industry of PTCA balloon catheter. In 2002-2009, China’s demand for PTCA balloon catheter kept an average annual growth rate of 38.1%, with the demand in 2009 recording 653,000 sets.

Demand of PTCA Balloon Catheter in China, 2002-2009 (1,000 sets)
2010123003.gif
Source: ResearchInChina

Due to limitations in technology and recognition, China lags behind in the development of PTCA balloon catheter industry although its import substitution ratio of coronary stent reached 78% in 2009. By contrast, China’s home-made degree of PTCA balloon dilatation catheter (excluding the part as stent transport system) was no more than 20% in 2009. Still, the market is dominated by foreign brands like Medtronic, Abbott Vascular, Boston Scientific, Goodman and Cordis.

Yet, Chinese PTCA balloon catheter market has gained widespread attention from investors worldwide since the breakthroughs in key technologies and the ever expanding market demand in China, and Chinese coronary stent manufacturers have increasingly sharpened the edge in the production of PTCA balloon catheter. As of Oct, 2010, well-known coronary stent suppliers at home such as Lepu Medical, Microport and Beijing Fuji Sunshine Technology are basically capable of producing PTCA balloon catheter for their own application, and they plan to further expand their output capacity of PTCA balloon catheter.

This report probes into the PTCA balloon catheter market of China in terms of current development, macro-economic situation, policy environment (including regional preferential policies), medical & health care level and market supply & demand, revealing the potential demand and investment opportunity of Chinese PTCA balloon catheter market.
1. Related Concepts of PTCA Balloon Catheter Industry
1.1 Definition & Classification of PTCA Balloon Catheter
1.2 Definition & Classification of Intervention Medical Device

2. Operating Environment of Chinese PTCA Balloon Catheter Market
2.1 Macro Economy
2.2 Policy Climate
2.3 Medical & Health Care Level
2.4 Status Quo of Chinese Medical Device Industry

3. Overview of Chinese PTCA Balloon Catheter Market
3.1 Status Quo
3.2 Development Bottleneck
3.3 Supply & Demand
3.3.1 Demand
3.3.1 Supply
3.4 Competition Pattern 

4. Investments in Chinese PTCA Balloon Catheter Market
4.1 Favorable Factors
4.1.1 Strong Support by National Industrial Policy
4.1.2 Financial Incentives
4.1.3 Expanding Market Demand
4.1.4 Increasingly Standardized Market
4.2 Unfavorable Factors
4.2.1 Mounting Risk of Price Drop
4.2.2 Shortage of Related Production Materials and Equipments
4.2.3 Foreign Non-Tariff Barriers
4.3 Economic Benefit
4.4 Choice for Plant Locations
4.4.1 Suzhou
4.4.2 Baoding
4.5 Construction of GMP Plant

5. Key Enterprises 
5.1 Lepu Medical
5.1.1 Profile 
5.1.2 Operation
5.1.3 Production
5.1.4 Prospect & Competitiveness
5.2 Microport
5.2.1 Profile
5.2.2 Operation
5.2.3 Production
5.2.4 Prospect
5.3 JW Medical
5.3.1 Profile
5.3.2 Operation
5.3.3 Production
5.4 Dalian Yinyi
5.4.1 Profile
5.4.2 Operation
5.4.3 Production
5.5 Neich Medical (Shenzhen)
5.5.1 Profile
5.5.2 Operation
5.5.3 Production
5.6 Beijing Fuji Sunshine Technology
5.6.1 Profile
5.6.2 Operation
5.6.3 Production
5.7 SCW Medicath Ltd
5.7.1 Profile
5.7.2 Operation
5.7.3 Production
5.8 SynexMed (Shenzhen)
5.8.1 Profile
5.8.2 Production
5.9 TemMed Medical
5.9.1 Profile
5.9. 2 Production
5.10 Changzhou JIUHONG Medical Instrument
5.10.1 Profile
5.10.2 Operation
Major Devices Used for PCI
Classification of Intervention Devices
Accumulated Value & Growth Rate of China’s GDP, 2007-2010 Q3
Laws and Regulations Related to Chinese Medical Device Industry
Industrial Polices Concerning PTCA Balloon Catheter Industry
Medical & Health Care Expenditure of China and Percentage in GDP, 2000-2009
Medical & Health Care Expenditure Make-ups and Changes in Proportions, 2000-2008 
Medical & Health Care Expenses of Urban and Rural Residents in China and Proportion in Their Consumption Expenditure, 2005-2008 
Gross Output Value of China’s Medical Device Industry, 2005-2009
Sales Revenue and Growth Rate of China’s Medical Device Industry, 2005-2009 
Main Financial Indices of China’s Medical Device Industry, 2005-2009
Market Share of China-made Coronary Drug Stent System, 2006-2009
China’s PCI Cases and Growth Rate, 2000-2009
Consumption and Growth Rate of Coronary Stent System in China, 2002-2009 
Volume of China’s Demand for Coronary Balloon Catheter, 2002-2009
High-value Medical Supplies and Additional Directory of PTCA Balloon Catheter Manufacturers in China, 2008
Main Brands and Market Shares of China’s Major Coronary Balloon Stent System by Consumption, 2009
Market Share Comparison between China-made and Imported Coronary Balloon Catheter, 2009
PCI Cases and Demand for PTCA Balloon Dilatation Catheter in China, 2010-2012
Regional Regulations on the Circulation and Application of Intervention Medical Device
Market Price of Main PTCA Balloon Catheter Brand Products in China, 2004 vs. 2008 
Operating Income, Total Profit and Gross Margin of China’s Artificial Limb, Artificial Organ and Intervention Medical Device Manufacturing, 2006-Aug. 2010
Preferential Policies of Major Industrial Parks in Suzhou
Average Annual Wage of Urban Workers in Jiangsu and Minimum Monthly Wage in Suzhou, 2006-Sep. 2010 
Average Annual Wage of Urban Workers in Hebei and Minimum Monthly Wage in Baoding, 2006-Sep. 2010
Cost Estimation of 100,000-level Clean Plant in China 
Equity Structure of Lepu Medical
Operating Income and Net Income of Lepu Medical, 2006- Q1-Q3,2010
Gross Margin of Major Products of Lepu Medical, 2006- H12010
Operating Income and Percentage of Lepu Medical by Product, 2006-2009
Major Product Capacity of Lepu Medical, 2006- H12010
Major Product Output of Lepu Medical, 2006-2009 
Major Product Sales Volume of Lepu Medical, 2006-2009
Unit Price of Major Products of Lepu Medical, 2006-2009
Operating Income Percentage of Lepu Medical by Region, 2009
Technical Parameters of PTCA Balloon Dilatation Catheter of Lepu Medical
Capacity and Output of Lepu Medical Coronary Balloon Catheter, 2006-2010 
R&D Expenditure and Its Proportion in Operating Income of Lepu Medical, 2006-2009
R&D Pattern of Lepu Medical
Projects to be Built with Raised Funds from Public Offerings by Lepu Medical, Oct. 2009
Lepu Medical Products First Having Passed CE Certification on Sep. 13, 2010
R&D Progress of Lepu Medical Products up to June 2010
MicroPort 18 Medical Device Products, as of Mar, 2010
MicroPort Operating Income & Net Income, 2007-H12010
MicroPort Stent Capacity & Output, 20007-2009
Sales Volume and Unit Price of MicroPort’s Major Stent Products, 2007- Q12010 
MicroPort’s Operating Income and Ratio by Product, 2007- H1 2010
MicroPort’s Operating Income by Region, 2007-H12010
Sales Volume of MicroPort’s Drug Stent Delivery System, 2007-Q12010
Specifications of MicroPort’s PTCA Coronary Dilatation Catheters
MicroPort’s Production of PTCA Coronary Dilatation Catheters, 2009-2010
MicroPort R&D Investment and Ratio to Operating Income, 2007-H12010
MicroPort Latest R&D of New Products, as of Sep, 2010
Operating Indices of Shandong JW Medical, 2007-2008
Operating Indices of Liaoning Biomedical Materials R&D Center Co., Ltd., 2008
Operating Indices of Neich Medical Shenzhen Co., Ltd., 2007-2008
Operating Indices of Beijing Fuji Sunshine Technology Co., Ltd., 2008
Operating Indices of SCW Medicath, Ltd., 2007-2008 
Technical Parameters of PTCA Balloon Catheter of SynexMed (Shenzhen) Co, Ltd.
PTCA Balloon Catheter Development Course of TemMed Medical Co., Ltd
Main Financial Indicators of Changzhou JIUHONG Medical Instrument Co., Ltd., 2008 

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号